Cargando…

The Influence of Gene Aberrations on Survival in Resected IDH Wildtype Glioblastoma Patients: A Single-Institution Study

This prospective population-based study on a group of 132 resected IDH-wildtype (IDH-wt) glioblastoma (GBM) patients assesses the prognostic and predictive value of selected genetic biomarkers and clinical factors for GBM as well as the dependence of these values on the applied therapeutic modalitie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalita, Ondrej, Sporikova, Zuzana, Hajduch, Marian, Megova Houdova, Magdalena, Slavkovsky, Rastislav, Hrabalek, Lumir, Halaj, Matej, Klementova, Yvona, Dolezel, Martin, Drabek, Jiri, Tuckova, Lucie, Ehrmann, Jiri, Vrbkova, Jana, Trojanec, Radek, Vaverka, Miroslav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025822/ https://www.ncbi.nlm.nih.gov/pubmed/33801093 http://dx.doi.org/10.3390/curroncol28020122

Ejemplares similares

IDH1/2 Mutations in Patients With Diffuse Gliomas: A Single Centre Retrospective Massively Parallel Sequencing Analysis
por: Sporikova, Zuzana, et al.
Publicado: (2022)

IDH Mutation Analysis in Glioma Patients by CADMA Compared with SNaPshot Assay and two Immunohistochemical Methods
por: Urbanovska, Irena, et al.
Publicado: (2018)

Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling
por: Slavik, Hanus, et al.
Publicado: (2020)

Pitfalls of commercially available HPV tests in HPV68a detection
por: Jaworek, Hana, et al.
Publicado: (2019)

Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma Recurrence
por: Slavik, Hanus, et al.
Publicado: (2022)

Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients
por: Rehulkova, Alona, et al.
Publicado: (2023)

Updates in IDH-Wildtype Glioblastoma
por: Melhem, Jawad M., et al.
Publicado: (2022)

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
por: Diplas, Bill H., et al.
Publicado: (2018)

Age-associated prognostic and predictive biomarkers in patients with breast cancer
por: Kolečková, Markéta, et al.
Publicado: (2017)

Distal Aneurysms of Cerebellar Arteries—Case Series
por: Krahulik, David, et al.
Publicado: (2020)

Evaluation of Non-Invasive Gargle Lavage Sampling for the Detection of SARS-CoV-2 Using rRT-PCR or Antigen Assay
por: Bouska, Ondrej, et al.
Publicado: (2022)

Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
por: Mareike, Müller, et al.
Publicado: (2021)

The prototype BS-II for computer measurement of biomechanical characteristics of the human cadaverous lumbar spine
por: Janák, Vladislav, et al.
Publicado: (2019)

Sensitivity of Papilledema as a Sign of Increased Intracranial Pressure
por: Krahulik, David, et al.
Publicado: (2023)

Methylation class oligosarcoma may encompass IDH-wildtype gliomas
por: Ebrahimi, Azadeh, et al.
Publicado: (2022)

PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma
por: Wang, Xuya, et al.
Publicado: (2022)

Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma
por: Liu, Elisa K, et al.
Publicado: (2022)

CBMS-1 Targeting amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomas
por: Ohba, Shigeo, et al.
Publicado: (2021)

Estimation of the occurrence rates of IDH1 and IDH2 mutations in gliomas and the reconsideration of IDH-wildtype anaplastic astrocytomas: an institutional experience
por: Cho, Uiju, et al.
Publicado: (2021)

Prognostic Analysis of the IDH1 G105G (rs11554137) SNP in IDH-Wildtype Glioblastoma
por: Saaid, Ayoub, et al.
Publicado: (2022)

Effects of Reoperation Timing on Survival among Recurrent Glioblastoma Patients: A Retrospective Multicentric Descriptive Study
por: Kalita, Ondrej, et al.
Publicado: (2023)

GEN-13 FIREWORK PATTERN OF CANCER GENESIS FOR GLIOBLASTOMA, IDH-WILDTYPE
por: Yoon, Seon-Jin, et al.
Publicado: (2019)

Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses
por: Liu, Yu-Qing, et al.
Publicado: (2019)

Role of CCND1 and C-MYC oncogenes in metastatic breast cancer patients treated by herceptin
por: Trojanec, R, et al.
Publicado: (2011)

Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities
por: Garrett, Matthew, et al.
Publicado: (2018)

Expression of CD133 Cancer Stem Cell Marker in IDH-Mutant and IDH-wildtype (Isocitrate Dehydrogenase) Astrocytoma
por: Sabunga, Olivia Desty, et al.
Publicado: (2022)

Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype: case series of a new entity
por: Bender, Katja, et al.
Publicado: (2023)

Role of Depression After Lumbar Disc Surgery
por: Hrabalek, Lumir
Publicado: (2011)

Primitive neuroectodermal tumor (PNET) of the lung in an adult woman
por: Gachechiladze, Mariam, et al.
Publicado: (2014)

Location-Dependent Patient Outcome and Recurrence Patterns in IDH1-Wildtype Glioblastoma
por: Jungk, Christine, et al.
Publicado: (2019)

Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
por: Radke, Josefine, et al.
Publicado: (2019)

Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres
por: Yoon, Seon-Jin, et al.
Publicado: (2020)

Glioblastoma, IDH-wildtype: A New Association with IgM Paraproteinaemic Neuropathy?
por: Lewis, Dana M., et al.
Publicado: (2022)

Glioblastoma, IDH-wildtype with leptomeningeal metastasis to Meckel’s cave: A case report
por: Murata, Toshiki, et al.
Publicado: (2022)

Initial Treatment of IDH-Wildtype Glioblastoma in Adults Older Than 70 Years
por: Bao, Jing, et al.
Publicado: (2023)

Distribution and favorable prognostic implication of genomic EGFR alterations in IDH ‐wildtype glioblastoma
por: Higa, Nayuta, et al.
Publicado: (2022)

Clinical Relevance of KRAS in Human Cancers
por: Jančík, Sylwia, et al.
Publicado: (2010)

Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia: Case report
por: Mensikova, Katerina, et al.
Publicado: (2016)

Immuno-phenotyping of IDH-mutant grade 3 astrocytoma and IDH-wildtype glioblastoma reveals specific differences in cells of myeloid origin
por: Raghavan, Jayashree V., et al.
Publicado: (2021)

XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype Glioblastoma
por: Le, Nguyen Quoc Khanh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d6jv17g4te8ooocl6likus470h